Ligang P. Chen

Luzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Migrasomes: new communicators between cells.

Migrasomes: new communicators between cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: April 08, 2026

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Journal: Cancer communications (London, England)

Published: November 22, 2025

Corynoline promotes apoptosis and inhibits proliferation of glioblastoma via regulating the STAT3/Bcl-2 signalling pathway.

Corynoline promotes apoptosis and inhibits proliferation of glioblastoma via regulating the STAT3/Bcl-2 signalling pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 25, 2025

Monocyte-to-high-density lipoprotein cholesterol ratio predicts hematoma expansion and poor outcomes in patients with spontaneous intracerebral hemorrhage.

Monocyte-to-high-density lipoprotein cholesterol ratio predicts hematoma expansion and poor outcomes in patients with spontaneous intracerebral hemorrhage.

Journal: BMC neurology

Published: August 13, 2025

Comment on "Multi-omics analysis of druggable genes to facilitate Alzheimer's disease therapy: A multi-cohort machine learning study".

Comment on "Multi-omics analysis of druggable genes to facilitate Alzheimer's disease therapy: A multi-cohort machine learning study".

Journal: The journal of prevention of Alzheimer's disease

Published: June 08, 2025

Reactive astrocytes in spinal cord injury: An analysis of heterogeneity based on temporality and spatiality, potential therapies, and limitations.

Reactive astrocytes in spinal cord injury: An analysis of heterogeneity based on temporality and spatiality, potential therapies, and limitations.

Journal: Journal of neuropathology and experimental neurology

Published: May 02, 2025

Correction: Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Correction: Therapeutic effect of fully human anti-Nrp-1 antibody on non-small cell lung cancer in vivo and in vitro.

Journal: Cancer immunology, immunotherapy : CII

Published: April 11, 2025

Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma.

Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma.

Journal: Frontiers in immunology

Published: March 25, 2025

Fimepinostat is a dual inhibitor of tumor and angiogenesis in glioblastoma and synergizes with temozolomide through suppressing MYC.

Fimepinostat is a dual inhibitor of tumor and angiogenesis in glioblastoma and synergizes with temozolomide through suppressing MYC.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: February 24, 2025

Commentary: Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.

Commentary: Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.

Journal: Frontiers in immunology

Published: February 16, 2025

Commentary: Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC.

Commentary: Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC.

Journal: Frontiers in immunology

Published: February 11, 2025

Limitations of nomogram models in predicting survival outcomes for glioma patients.

Limitations of nomogram models in predicting survival outcomes for glioma patients.

Journal: Frontiers in immunology

Published: December 18, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026